Most patients with persistent pulmonary symptoms after recovering from mild to moderate COVID-19 infection have normal pulmonary PFT results.
Impaired lung function is associated with both the prevalence and incidence of SpA, with the strongest effects observed in axSpA and AS.
Today's call will feature prepared comments by Will Lewis, Chair and Chief Executive Officer; Roger Adsett, Chief Operating Officer; and Sara Bonstein, Chief Financial Officer. After their comments, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback